Collection
MeSH Terms
Renal Insufficiency (C12.050.351.968.419.780);
Renal Dialysis (E02.870.300, E02.912.800) ; Kidney Diseases (C12.050.351.968.419);
Renal Insufficiency, Chronic (C12.050.351.968.419.780.750);
Middle East (Z01.252.245.500); Saudi Arabia (Z01.252.245.500.750); Antihypertensive Agents (D27.505.954.411.162);
Angiotensin-Converting Enzyme Inhibitors (D27.505.519.389.745.085); Angiotensin Receptor Antagonists (D27.505.519.162); Adrenergic beta-Antagonists )D27.505.519.625.050.200.200); Adrenergic alpha-Antagonists (D27.505.519.625.050.200.100); Diuretics (D27.505.696.560.500); Calcium Channel Blockers (D27.505.519.562.249); Renal Replacement Therapy (E02.870); Attitude to Health (F01.100.150, N05.300.150); Hypertension, Renal (C12.050.351.968.419.331)
Keywords
chronic kidney disease; clinical practice guideline; blood pressure measurement; antihypertensive agents; kidney replacement therapy
Date for Review
29/04/2027
Expected Publication Date
29/04/2022
Date of Last Evidence Search
10/01/2021
Methods Applied
GRADE-ADOLOPMENT; AGREE II; Systematic review; Risk of Bias; GRADE
Guideline Contact
Dr Khalid Alhasan
Publication Scope
assessment
counselling
management
Patient education
treatment
Countries of Application
Kingdom of Saudi Arabia
Guideline Publication Status
Development
Languages
English
Authors
Saudi CKD Group
Willingness to Collaborate
No